Literature DB >> 28776093

Identification of an atypical microdeletion generating the RNF135-SUZ12 chimeric gene and causing a position effect in an NF1 patient with overgrowth.

Luca Ferrari1, Giulietta Scuvera2, Arianna Tucci2, Donatella Bianchessi3, Francesco Rusconi1, Francesca Menni2, Elena Battaglioli1, Donatella Milani4, Paola Riva5.   

Abstract

Neurofibromatosis type I (NF1) microdeletion syndrome, which is present in 4-11% of NF1 patients, is associated with a severe phenotype as it is caused by the deletion of NF1 and other genes in the 17q11.2 region. The variable expressivity of the disease makes it challenging to establish genotype-phenotype correlations, which also affects prognosis and counselling. We here describe a 3-year-old NF1 patient with an atypical deletion and a complex phenotype. The patient showed overgrowth, café au lait spots, inguinal freckling, and neurological abnormalities. The extent of the deletion was determined by means of array comparative genomic hybridisation, and its breakpoints were isolated by means of long-range polymerase chain reaction. Sequence analysis of the deletion junction fragment revealed the occurrence of an Alu-mediated recombination that led to the generation of a chimeric gene consisting of three exons of RNF135 and eleven exons of SUZ12. Interestingly, the deletion shares a common RNF135-centred region with another deletion described in a non-NF1 patient with overgrowth. In comparison with the normal RNF135 allele, the chimeric transcript was 350-fold over-expressed in peripheral blood, and the ADAP2 gene located upstream of RNF135 was also up-regulated. In line with this, the deletion causes the loss of a chromatin TD boundary, which entails the aberrant adoption of distal cis-acting regulatory elements. These findings suggest that RNF135 haploinsufficiency is related to overgrowth in patients with NF1 microdeletion syndrome and, for the first time, strongly indicate a position effect that warrants further genotype-phenotype correlation studies to investigate the possible existence of previously unknown pathogenic mechanisms.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28776093     DOI: 10.1007/s00439-017-1832-5

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  49 in total

1.  Evidence for non-homologous end joining and non-allelic homologous recombination in atypical NF1 microdeletions.

Authors:  Marco Venturin; Cristina Gervasini; Francesca Orzan; Angela Bentivegna; Lucia Corrado; Patrizia Colapietro; Alessandra Friso; Romano Tenconi; Meena Upadhyaya; Lidia Larizza; Paola Riva
Journal:  Hum Genet       Date:  2004-04-21       Impact factor: 4.132

2.  Mosaic type-1 NF1 microdeletions as a cause of both generalized and segmental neurofibromatosis type-1 (NF1).

Authors:  Ludwine Messiaen; Julia Vogt; Kathrin Bengesser; Chuanhua Fu; Fady Mikhail; Eduard Serra; Carles Garcia-Linares; David N Cooper; Conxi Lazaro; Hildegard Kehrer-Sawatzki
Journal:  Hum Mutat       Date:  2011-02       Impact factor: 4.878

3.  Analysis of crossover breakpoints yields new insights into the nature of the gene conversion events associated with large NF1 deletions mediated by nonallelic homologous recombination.

Authors:  Kathrin Bengesser; Julia Vogt; Tanja Mussotter; Victor-Felix Mautner; Ludwine Messiaen; David N Cooper; Hildegard Kehrer-Sawatzki
Journal:  Hum Mutat       Date:  2013-12-02       Impact factor: 4.878

4.  Identification of recurrent type-2 NF1 microdeletions reveals a mitotic nonallelic homologous recombination hotspot underlying a human genomic disorder.

Authors:  Julia Vogt; Tanja Mussotter; Kathrin Bengesser; Kathleen Claes; Josef Högel; Nadia Chuzhanova; Chuanhua Fu; Jenneke van den Ende; Victor-Felix Mautner; David N Cooper; Ludwine Messiaen; Hildegard Kehrer-Sawatzki
Journal:  Hum Mutat       Date:  2012-08-20       Impact factor: 4.878

5.  ADAP2 in heart development: a candidate gene for the occurrence of cardiovascular malformations in NF1 microdeletion syndrome.

Authors:  Marco Venturin; Silvia Carra; Germano Gaudenzi; Silvia Brunelli; Guido Roberto Gallo; Silvia Moncini; Franco Cotelli; Paola Riva
Journal:  J Med Genet       Date:  2014-04-07       Impact factor: 6.318

6.  Elevated risk for MPNST in NF1 microdeletion patients.

Authors:  T De Raedt; H Brems; P Wolkenstein; D Vidaud; S Pilotti; F Perrone; V Mautner; S Frahm; R Sciot; E Legius
Journal:  Am J Hum Genet       Date:  2003-03-26       Impact factor: 11.025

7.  Copy number variations in the NF1 gene region are infrequent and do not predispose to recurrent type-1 deletions.

Authors:  Katharina Steinmann; Lan Kluwe; David N Cooper; Hilde Brems; Thomas De Raedt; Eric Legius; Viktor-Felix Mautner; Hildegard Kehrer-Sawatzki
Journal:  Eur J Hum Genet       Date:  2008-01-23       Impact factor: 4.246

8.  NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience.

Authors:  Audrey Sabbagh; Eric Pasmant; Apolline Imbard; Armelle Luscan; Magali Soares; Hélène Blanché; Ingrid Laurendeau; Salah Ferkal; Michel Vidaud; Stéphane Pinson; Christine Bellanné-Chantelot; Dominique Vidaud; Béatrice Parfait; Pierre Wolkenstein
Journal:  Hum Mutat       Date:  2013-08-26       Impact factor: 4.878

9.  Effect of the oligodendrocyte myelin glycoprotein (OMgp) on the expansion and neuronal differentiation of rat neural stem cells.

Authors:  Isabelle Martin; Christian R Andres; Sylviane Védrine; Refaat Tabagh; Caroline Michelle; Marie-Lise Jourdan; Nathalie Heuze-Vourc'h; Philippe Corcia; Anne Duittoz; Patrick Vourc'h
Journal:  Brain Res       Date:  2009-06-06       Impact factor: 3.252

10.  Absence of cutaneous neurofibromas in an NF1 patient with an atypical deletion partially overlapping the common 1.4 Mb microdeleted region.

Authors:  Hildegard Kehrer-Sawatzki; Eva Schmid; Carsten Fünsterer; Lan Kluwe; Victor-Felix Mautner
Journal:  Am J Med Genet A       Date:  2008-03-15       Impact factor: 2.802

View more
  5 in total

Review 1.  Warning SINEs: Alu elements, evolution of the human brain, and the spectrum of neurological disease.

Authors:  Peter A Larsen; Kelsie E Hunnicutt; Roxanne J Larsen; Anne D Yoder; Ann M Saunders
Journal:  Chromosome Res       Date:  2018-02-19       Impact factor: 5.239

Review 2.  Non-Coding RNA and Tumor Development in Neurofibromatosis Type 1: ANRIL Rs2151280 Is Associated with Optic Glioma Development and a Mild Phenotype in Neurofibromatosis Type 1 Patients.

Authors:  Viviana Tritto; Luca Ferrari; Silvia Esposito; Paola Zuccotti; Donatella Bianchessi; Federica Natacci; Veronica Saletti; Marica Eoli; Paola Riva
Journal:  Genes (Basel)       Date:  2019-11-05       Impact factor: 4.096

Review 3.  Atypical NF1 Microdeletions: Challenges and Opportunities for Genotype/Phenotype Correlations in Patients with Large NF1 Deletions.

Authors:  Hildegard Kehrer-Sawatzki; Ute Wahlländer; David N Cooper; Victor-Felix Mautner
Journal:  Genes (Basel)       Date:  2021-10-19       Impact factor: 4.096

Review 4.  Classification of NF1 microdeletions and its importance for establishing genotype/phenotype correlations in patients with NF1 microdeletions.

Authors:  Hildegard Kehrer-Sawatzki; David N Cooper
Journal:  Hum Genet       Date:  2021-09-18       Impact factor: 4.132

5.  Characterization of 22q12 Microdeletions Causing Position Effect in Rare NF2 Patients with Complex Phenotypes.

Authors:  Viviana Tritto; Marica Eoli; Rosina Paterra; Serena Redaelli; Marco Moscatelli; Francesco Rusconi; Paola Riva
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.